Belviq bests Qsymia in weekly scripts

TRx and NRx for Belviq (ARNA) were up 10% and 9% last week respectively, outstripping Qsymia (VVUS) TRx and NRx growth of 7% and 6%.

From other sites
Comments (8)
  • anomaly1
    , contributor
    Comments (1058) | Send Message
    Belviq is gaining mkt share. Hold on for $10+ ARNA
    23 Aug 2013, 09:36 AM Reply Like
  • Gtg007
    , contributor
    Comments (114) | Send Message
    Awesome..Double digits soon for Arna!
    23 Aug 2013, 09:38 AM Reply Like
  • highstandard
    , contributor
    Comments (77) | Send Message
    And the Rx numbers are?
    23 Aug 2013, 09:50 AM Reply Like
  • Day Trader001
    , contributor
    Comments (779) | Send Message


    Time for the ARNA negative articles to come slithering out of the woodwork!!
    23 Aug 2013, 09:51 AM Reply Like
  • beachie
    , contributor
    Comments (37) | Send Message
    without the volme of weekly / monthly percentages mean nothing..dumb article...i like both stks
    23 Aug 2013, 11:18 AM Reply Like
  • BudTuba
    , contributor
    Comments (34) | Send Message
    Predicting the future on weekly data is fraught with risk that issues that affect sales take time to make an impact. I believe that Belviq will respond to social media from people who are taking the drug, but that requires them to see some results. The degree of response will vary from person to person. Anecdotal comments will also help, like "feeling full", "feeling euphoric", "been able to reduce my insulin", "my doctor is very happy with my results"..etc. These are starting to show up, but won't really happen until they are close to their three month checkup and receiving continuing prescriptions. To be totally unbiased about this, this social media effect will also apply to Qysmia. It will be interesting to see if either drug has more popular response than the other.
    23 Aug 2013, 12:15 PM Reply Like
  • Chris Lau
    , contributor
    Comments (3986) | Send Message
    (ARNA) is a $12 stock trading at 7. Good news to longs. Enjoy the bumpy ride up as script numbers grow.
    23 Aug 2013, 12:35 PM Reply Like
  • New Superhuman
    , contributor
    Comments (1180) | Send Message
    Absolutely. See you at $12.
    23 Aug 2013, 02:41 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs